Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Genky DrugStores Co., Ltd. ( (JP:9267) ) just unveiled an update.
Genky DrugStores reported solid year-on-year sales growth for March in both all stores and existing stores, supported by rising customer traffic despite slightly weaker spending per customer. The company continues to standardize its network, opening only regular-format stores and converting larger outlets, which helped lift total store count to 510 as of March and underpinned double-digit net sales growth at the company-wide level for the current fiscal year to date.
Existing-store sales advanced at a more modest pace than overall sales, indicating that expansion through new outlets remains the primary growth driver. For stakeholders, the data highlight a strategy centered on disciplined format standardization and aggressive store rollout, which is sustaining revenue momentum even as per-customer spending shows signs of leveling off.
The most recent analyst rating on (JP:9267) stock is a Buy with a Yen4318.00 price target. To see the full list of analyst forecasts on Genky DrugStores Co., Ltd. stock, see the JP:9267 Stock Forecast page.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. operates a drugstore chain listed on the TSE Prime, focusing on standardized 300-tsubo regular-format outlets. The company concentrates on pharmacy-related retail and daily necessities, pursuing network expansion mainly through new store openings and the refurbishment of larger formats into standardized regular stores.
Average Trading Volume: 109,192
Technical Sentiment Signal: Buy
Current Market Cap: Yen120.6B
For a thorough assessment of 9267 stock, go to TipRanks’ Stock Analysis page.